Skip to main content

2 Result(s)

within H. Büller Remove this filter Pediatrics Remove this filter

and

  1. No Access

    Article

    Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects

    Objective: Impairment of haemostasis has been described with slowly degradable medium molecular weight hydroxyethyl starch (MMW-HES), whereas rapidly degradable MMW-HES is generally considered to...

    E. de Jonge, M. Levi, H. Büller, F. Berends, J. Kesecioglu in Intensive Care Medicine (2001)

  2. No Access

    Article

    Vitamin-K status beyond the neonatal period

    Vitamin K-dependent clotting factors (FII, FVII, FX) and PT and TT were studied prospectively in 113 healthy newborns during the first 6 weeks of life. No vitamin K prophylaxis was given. Infants were divided ...

    H. Büller, M. Peters, B. Burger, N. Nagelkerke… in European Journal of Pediatrics (1986)